|
Jul 25
|
Why Weight Loss Drug Developer Stocks Tumbled on Thursday
|
|
Jul 25
|
Viking Therapeutics Unveils Monthly Weight-Loss Shot, Rocking Eli Lilly, Novo Nordisk
|
|
Jul 25
|
Why Viking’s Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk Stocks
|
|
Jul 25
|
European regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse cardiovascular events
|
|
Jul 25
|
Viking Stock Jumps After Company Speeds Development Its Weight-Loss Pill
|
|
Jun 26
|
How consumer spending, election impact markets: Market Domination
|
|
Jun 26
|
Lawmakers to vote on if Medicare could cover obesity drugs
|
|
Jun 26
|
Novo Nordisk Halts Late-Stage Study Of Experimental Hypertension Drug, Takes Over $800M Impairment Charge
|
|
Jun 26
|
The S&P 500 and Nvidia, Chipotle stock split: Morning Brief
|
|
Jun 26
|
Novo nixes trial of blood pressure drug it bought in deal worth $1.3B
|
|
Jun 26
|
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment
|
|
Jun 26
|
Update: Novo Nordisk to Take $816.2 Million Impairment Loss After Stopping Clarion-CKD Trial
|
|
Jun 26
|
Yahoo Video: Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
|
|
Jun 26
|
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss
|
|
Jun 26
|
Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
|
|
Jun 26
|
Dow Jones Futures Fall; Tesla Rival Rivian Skyrockets, Nvidia Gets Price Target Hike
|
|
Jun 26
|
Novo Nordisk’s Wegovy may just have two years to take over China’s market for weight loss drugs
|
|
Jun 25
|
Novo Nordisk soars, Biden vs. Trump, French Markets: Market Domination
|
|
Jun 25
|
Novo Nordisk stock rises on Wegovy approval in China
|
|
Jun 25
|
Novo Nordisk's Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows
|